Day: March 20, 2023

Nes-Ziona, Israel, March 20, 2023 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that an independent Data and Safety Monitoring Board (DSMB) has completed an interim data review for the first cohort of patients in the Company’s ongoing Phase I/II clinical trial of Allocetra™ in patients with advanced-stage peritoneal metastasis arising from solid tumors as an add-on to the standard of care (SoC) chemotherapy administered via Pressurized Intraperitoneal Aerosol Chemotherapy (clinicaltrials.gov Identifier: NCT05431907). The Israeli Ministry of Health (IMOH) also reviewed the interim data and provided regulatory clearance to continue the study and open the study’s next cohort. In addition, the safety profile supported...

Amended Credit Facility to Focus on Retail and Institutional Investor Awareness ARLINGTON, Va., March 20, 2023 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. (TSXV: CTRL, OTCQB: UNFYF, FSE: Q5i)(“edgeTI”, “We”, “Our” or the “Company”), announces that it has amended its line of credit facility (the “Credit Facility”) with Lotus Domaine III LP (“Lotus”), an investment fund which is also a significant shareholder of the Company. “This amendment increases our line of credit and adds the Company’s election to convert this debt into common shares, which when executed will improve our debt ratio and other related metrics as we look to reach cash-flow positive operations”, remarked Jim Barrett, CEO of edgeTI. “The increase intends to better support existing and new investors and prepare edgeTI for growth as we help customers...

Figure 1: Stress levels in treated rats (as indicated by self-harm) An indicator of stress in laboratory rats is a propensity for self-harm. The stress level of the rats was found to be correlated with functional recovery, i.e. recovered rats did not exhibit self-harm.TORONTO and TEL AVIV, Israel, March 20, 2023 (GLOBE NEWSWIRE) — Toronto and Tel Aviv, March 20, 2023 – Biopharmaceutical firm NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (“NurExone” or the “Company”), disclosed today additional results from an internal preclinical study of its investigational drug ExoPTEN demonstrating effective treatment of 75% of paralyzed rats suffering from spinal cord injuries. The Company’s most recent preclinical trials, that have taken place over 10 weeks in NurExone’s labs in Israel, have proven that its experimental drug...

Represents Societal CDMO’s First Commercially Manufactured Tablet Product, Expanding Beyond Expertise in Commercial Capsules SAN DIEGO, Calif. and GAINESVILLE, Ga., March 20, 2023 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the United States Food and Drug Administration (FDA) has approved the company as a manufacturer of a commercial tablet product. Societal CDMO expects to begin commercial manufacturing of the product at its Gainesville, Georgia facilities later this year. “This FDA approval, which represents the first commercial tablet that Societal CDMO has been approved to manufacture,...

HOUSTON, March 20, 2023 (GLOBE NEWSWIRE) — Amplify Energy Corp. (“Amplify” or the “Company”) (NYSE: AMPY) today announced that Dan Furbee has joined the Company as Senior Vice President and Chief Operating Officer. “I am excited to announce that Dan has decided to join Amplify. Dan will be a valuable addition to the management team and brings extensive operational and managerial experience to the Company that will help maximize the value of our cash flow generating properties,” said Martyn Willsher, President and Chief Executive Officer. Prior to joining Amplify, Mr. Furbee served as a partner at Sentinel Petroleum from February 2022 to March 2023 and as an independent advisor for various companies from January 2021 to January 2022. Previously, Mr. Furbee served as the Executive Vice President and Chief Operating Officer of Riviera...

– Positive neuroprotective effect of vorolanib, the active drug in EYP-1901, in a widely validated retinal detachment model demonstrates a potential new mechanism of action for the treatment of retinal disease – – Clinical outcomes from real-world CALM registry study of YUTIQ® demonstrates effective control of inflammation in chronic posterior segment uveitis – WATERTOWN, Mass., March 20, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced multiple scientific presentations at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, being held April 23 – 27 in New Orleans, Louisiana. “We are excited to be presenting these...

$ 1.68 Million in Funding for Capabilities and Capacity Expansions MISSISSAUGA, Ontario, March 20, 2023 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is undertaking further expansions to its capabilities and capacity for manufacturing specialized products relating to diagnostic testing for infectious diseases. The Government of Ontario is supporting the expansions at Microbix’s three adjacent sites in Mississauga with a grant of $ 840,000 from the Ontario Together Fund (“OTF”). A separate $ 840,000 of interest-free loan funding has also been provided by the Government of Canada through its FedDev Ontario program. The balance of costs will be provided by Microbix from its current funds or ongoing cash flow. This project has...

BOREO PLC   STOCK EXCHANGE RELEASE   20 March 2023 AT 13:00 EET NOTICE TO THE ANNUAL GENERAL MEETING OF BOREO PLC Notice is given to the shareholders of Boreo Plc (“Boreo”) to the Annual General Meeting (the “General Meeting”) to be held on Wednesday, 19 April 2023 at 2:00 p.m. (EET) at Ansatie 5, 01740 Vantaa. The shareholders may participate to the General Meeting only at the meeting venue. The reception of persons who have registered for the General Meeting and the distribution of voting tickets will commence at 1:30 p.m. (EET). The shareholders are provided the option to exercise their voting rights without having to be physically present at the General Meeting by voting in advance. For further instructions, please refer to Section C.4 “Advance Voting” of this notice. A. Matters on the Agenda of the General Meeting At the General Meeting,...

TORONTO, March 20, 2023 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of its latest generation of ARTAS iX, which is now broadly available to physicians specializing in hair transplantation worldwide. Its latest generation of ARTAS iX sets a new standard for hair transplantation by leveraging cutting-edge robotics, machine vision, artificial intelligence, and machine learning technologies. This advanced system offers a new level of speed to the implantation process, now allowing the implantation of up to 1000 grafts per hour while also improving the speed of harvesting, resulting in a procedure that is up to 25% faster. Additional improvements include the new vision system, which improves patient...

MONTREAL, March 20, 2023 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW; “BRW” or the “Company”) is pleased to announce that it has begun drilling at the Anatacau West project, located in the Eeyou-Istchee James Bay region of Quebec. A 3,000-metre drill program is targeting the potential eastern extension of Allkem’s James Bay lithium deposit in an area that has yet to be drill-tested. The Company is also planning to sample and analyze historical pegmatite-bearing core at the PLEX project prior to the end of the month followed by the start of another drill program at the Hearst Project located in eastern Ontario in early Q2. Mr. Killian Charles, President and CEO of BRW, commented: “This will be a transformational year for BRW as we commence multiple drilling and stripping programs across Canada, while conducting aggressive...